• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

When Looking for Market Help, Rigor Is Essential

USA Today's '9 Stocks' story doesn't consider data essential to its narrative.
By SEBASTIAN SILVA Aug 25, 2015 | 12:01 PM EDT
Stocks quotes in this article: PLL, DHR, SIAL, HSP, PFE, AGL, SO

As often happens when the market goes haywire, there's attempt to get as many what-can-I-do stories out as possible. And today's USA Today piece -- "Look out! 9 big stocks still aren't cheap." -- raises some eyebrows about its validity. It warns about stocks being overvalued, but fails to take into account takeover bid for more than half of those companies.

How'd they determine that they're overvalued? Nine stocks in the Standard & Poor's 500 are still trading above analysts' 18-month price targets, according to a USA Today analysis of data from S&P Capital IQ.

The problem? Again, most of those names are up because they will be bought.

We're wondering if these names were even checked beyond meeting a simple (and quite irrelevant) criterion like price targets when the companies in question are involved in deals. My gut tells me that this article may not have even been written if the analysis included these M&A facts.

While you could say the good intentions were there, the article is misleading.

So what did this article fail to tell you?

Sysco (SYY) just had an activist move and new board members from Trian. Nelson Peltz's Trian Partners has taken a more than 7% stake in the food service company, worth around $1.6 billion, about 42 million shares.

Pall (PLL) made the list closing yesterday at $126.27 vs. its 18-month target of $119.45. But there is no mention of the almost 30% surge in the name since early May after the water filtration systems maker announced that it had agreed to be acquired by Danaher (DHR) for $127.20 per share, or $13.8 billion. The target is worthless.

Sigma-Aldrich (SIAL) made the cut, too, but again, no mention that the stock has risen more than 30% since the German pharmaceutical company Merck KGaA said last September that it would pay about $17 billion to acquire the U.S. supplier of laboratory testing materials. Bogus target.

Even the injectable pharmaceutical drug company Hospira (HSP) made it on this overvalued list, with no mention of it rocketing over 40% since Pfizer (PFE) agreed to buy it in early February.

Only the natural gas distributor AGL Resources (AGL) got a cursory note about how utility Southern Co. (SO) said it would buy the company for $8 billion in cash this week. But the article mentions it as an afterthought, as if the bid was some sort of secondary piece of information and not the biggest single factor to consider when valuing this company. The stocked popped almost 30% yesterday on the news.

Of course these stocks are over their price targets here, not to mention that most analysts drop their targets (and ratings/coverage) often when a company is acquired.

When the markets get shocked, it's natural for the media to try and capture as much coverage as possible, even using fear to its advantage. Just walk in front of the NYSE, between yesterday and this morning and you'll see the make-shift TV sets have sprung up like Wall Street weeds. But c'mon, this is just wrong.

A little research goes a long way, and we'd be mindful to read between the lines, especially when sifting through the rank research (or lack thereof) and trying to assign new or relative value to stocks amid this selloff.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities

TAGS: Stocks | Investing | U.S. Equity

More from Stocks

If It Growls Like a Bear and Smells Like a Bear ....

James "Rev Shark" DePorre
Apr 20, 2021 4:29 PM EDT

We are no longer in a bull market that will forgive our mistakes, so take precautionary measures. Here are a few I recommend.

Taking a Look at IBM's Technical Turnaround

Bruce Kamich
Apr 20, 2021 3:13 PM EDT

Here's where to go long.

Jim Cramer: We're Back to the Market That Baffles

Jim Cramer
Apr 20, 2021 3:08 PM EDT

Welcome to the 'new' old world -- the world we had before all the new people and their money came into the market.

No Longer a Boom or Bust Cyclical Stock, Micron Technology Has Found Consistency

Timothy Collins
Apr 20, 2021 2:42 PM EDT

Here's where I would consider getting long.

MicroVision's Charts Are Pointed Lower

Bruce Kamich
Apr 20, 2021 2:10 PM EDT

Avoid the long side of MVIS.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:17 PM EDT REAL MONEY

    Wednesday on Real Money Pro

    Get-rich quick schemes offer little more than pipe...
  • 11:09 AM EDT GARY BERMAN

    S&P Futures

    FIBOCALL: The S&P futures was off 1.5 %... ...
  • 07:47 AM EDT CHRIS VERSACE

    Positive News for a Cannabis Play

    Good news for this name in the Stocks Under $10 po...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login